These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 960746)

  • 1. [Problems of immuno- and mesenchyma-suppressive therapy of inflammatory liver diseases].
    Zipprich B; Busse HJ; Nilius R; Otto L
    Z Arztl Fortbild (Jena); 1976 Jan; 70(2):62-6. PubMed ID: 960746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathologic observations on the treatment with antimetabolites in primary chronic polyarthritis and hepatitis].
    Gerlach U
    Med Welt; 1967 Dec; 49():2982-5. PubMed ID: 5608854
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive therapy in chronic inflammatory liver diseases].
    Deicher H
    Verh Dtsch Ges Inn Med; 1972; 78():765-7. PubMed ID: 4665750
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W; Emmrich R; Petzold H
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive therapy of chronic hepatitis].
    Meyer zum Büschenfelde
    Dtsch Med J; 1969 Aug; 20(16):522-7. PubMed ID: 5344061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic hepatitis with immunosuppressive agents].
    Cachin M
    Therapeutique; 1972 Jan; 48(1):57-60. PubMed ID: 5046371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological changes during the treatment of chronic liver diseases with immunosuppressive agents].
    Zivković R; Babić D; Radosević V; Sket-Janković N; Bogdan I; Vercko K; Varlaj V
    Acta Med Iugosl; 1976; 30(5):497-508. PubMed ID: 1015350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basis of immunosuppressive effect of D-penecillamine].
    Schumacher K
    Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252
    [No Abstract]   [Full Text] [Related]  

  • 10. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of lymphocyte subpopulations by stimulation with polyclonal mitogens in chronic liver diseases].
    Nicolaescu T; Bordea M; Bordeianu A; Bittman E; Stoiculescu P; Udrescu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):167-74. PubMed ID: 6139862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunopathology of chronic hepatitis and results of therapy with cytostatics].
    Schmidt E; Schmidt FW
    Dtsch Med J; 1969 Aug; 20(15):465-71. PubMed ID: 4898975
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunopathogenesis of chronic inflammatory liver diseases].
    Meyer zum Büschenfelde
    Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatment.
    Salerno F; Tornaghi G; Cappellini MD; Fargion S; Fiorelli G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:272. PubMed ID: 4851922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy of chronic aggressive hepatitis].
    Maleev A; Stojanov S
    Z Gesamte Inn Med; 1973 Oct; 28(20):Suppl:307-9. PubMed ID: 4767201
    [No Abstract]   [Full Text] [Related]  

  • 16. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies].
    Carotti A
    Minerva Med; 1980 Nov; 71(47):3429-34. PubMed ID: 7454095
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic problems in liver diseases].
    Renger F
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:120-3. PubMed ID: 5402567
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the diagnosis and therapy of hepatitis with autoaggressive characteristics].
    Schneider W
    Verh Dtsch Ges Inn Med; 1968; 74():537-9. PubMed ID: 5714379
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis.
    Lambiase L; Davis GL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):659-77. PubMed ID: 1381338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.